Screener
Inspire Medical Systems INSP Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Inspire Medical Systems in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Inspire Medical Systems’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001609550-26-000023
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Stockholders' equity: | ||
| Preferred Stock, $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding | — | — |
| Common Stock, $0.001 par value; 200,000,000 shares authorized; 28,802,039 and 28,579,015 issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 29 | 29 |
| Additional paid-in capital | 950,449 | 927,159 |
| Accumulated other comprehensive (loss) income | (352) | 464 |
| Accumulated deficit | (157,786) | (146,492) |
| Total stockholders' equity | 792,340 | 781,160 |
| Total liabilities and stockholders' equity | $911,376 | $907,317 |
Item 1. Financial Statements.
FAQ
- What is Inspire Medical Systems's retained earnings?
- Inspire Medical Systems (INSP) reported retained earnings of -$157.79M in Q1 2026.
- How has Inspire Medical Systems's retained earnings changed year-over-year?
- Inspire Medical Systems's retained earnings increased by 45.4% year-over-year, from -$288.92M to -$157.79M.
- What is the long-term trend for Inspire Medical Systems's retained earnings?
- Over 5 years (2020 to 2025), Inspire Medical Systems's retained earnings has grown at a -9.2% compound annual growth rate (CAGR), from -$237.35M to -$146.49M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Inspire Medical Systems's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude